Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RALGPS2 antisense RNA 1 (RALGPS2-AS1)
- Target
- RALGPS2-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA, Non-protein-coding transcript
01
Overview
RALGPS2 antisense RNA 1 (RALGPS2-AS1, also known as lnc-ANGPTL1-3) is a long non-coding antisense transcript located opposite the RALGPS2 gene locus[4]. Antisense RNAs are known to play key roles in the regulation of gene expression, often at the epigenetic or transcriptional level, by mechanisms including transcriptional interference and modulation of chromatin structure[2]. While many antisense lncRNAs are being investigated for their roles in diseases—particularly cancer—no specific functional or disease associations have been definitively reported for RALGPS2-AS1 as of this search. There are currently no drugs known to interact with RALGPS2-AS1, and it is not considered a validated therapeutic target in pharmacology or clinical development[4][2].
- Other names
- lnc-ANGPTL1-3RALGPS2-AS1RALGPS2 antisense RNA 1
02
Mechanism of action
None known for direct pharmacologic targeting As a class, antisense RNAs can regulate sense gene expression by transcriptional interference, chromatin modification, or RNA-RNA interactions, but RALGPS2-AS1-specific mechanisms are not described
03
Biological functions
Regulation of gene expressionEpigenetic regulationPotential chromatin structure modulation
04
Disease associations
Not specifically described for RALGPS2-AS1By analogy with other antisense lncRNAs, potential roles in cancer or epigenetic disorders are possible, but no direct evidence was found in the literature as of this search
05
Safety considerations
None reported
06
Interacting drugs
None known
07
Biomarkers
None reported for RALGPS2-AS1Antisense lncRNAs as a general class may serve as biomarkers, but this has not been specifically described for this molecule
Beyond the preview
Go deeper on RALGPS2 antisense RNA 1 (RALGPS2-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RALGPS2 antisense RNA 1 (RALGPS2-AS1).